Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

Scil Proteins GmbH

Scil Proteins is a private protein engineering company that is focused on generating and optimizing unique Affilin®-based protein therapeutics and non-therapeutic applications using its proprietary flexible and modular Affilin® platform for partners in the pharmaceutical, biotech and life science industries. Affilin®-based molecules are derived from human scaffold proteins and have high stability, affinity and specificity making them ideal for a range of applications that demand targeting and capturing of biomolecules. The unique properties of these Affilin®-based molecules  overcome several of the limitations of antibodies, especially in specific niche applications.

The company’s core business areas include the development of drug conjugates and multi-specific protein binding molecules, as well as ligands for non-therapeutic applications. All of these core areas are underpinned by state-of-the-art protein engineering technologies and a team with an unrivalled depth of expertise and track record in this area, making Scil Proteins an attractive partner.

Details


Adresse:
Scil Proteins GmbH

Heinrich-Damerow-Str. 1
06120 Halle
Deutschland
Arbeitsgebiet:
Forschung & Entwicklung
Sonstige Tätigkeitsfelder
Expansion:
international
Mitarbeiteranzahl:
11-50
Gründungsjahr:
1999